What's happening
This bill prohibits drug, cannabis, or alcohol testing and screening of pregnant or postpartum individuals and newborns without informed consent, except in emergencies.
Why it matters
Reduces risk of non-consensual legal or child welfare consequences. By requiring explicit informed consent for drug, cannabis, or alcohol testing/screening, the bill aims to protect pregnant and postpartum individuals, and parents of newborns, from potentially triggering automatic reports to child protective services and other legal actions without their knowledge.
Empowers patients with knowledge and choice. The legislation mandates that patients are informed about the purpose, confidentiality, and possible legal ramifications of tests or screens, giving them the opportunity to consult legal counsel and make truly informed decisions regarding their medical care.
Addresses health equity and potential bias. Routine or non-consensual testing has been shown to disproportionately affect marginalized communities. This bill may help reduce discriminatory practices and ensure that care is based on medical need rather than suspicion or profiling.
Limits unnecessary medical interventions and promotes trust. By prohibiting these tests unless they are medically necessary and consented to (except in emergencies), the bill seeks to foster a more trusting relationship between patients and healthcare providers, and prevent refusal of care based on a patient’s decision not to be tested.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Pregnant and postpartum patients
The bill would require specific informed consent for drug, cannabis or alcohol testing and screening through one year postpartum, with an emergency exception, and prohibit denial of treatment for refusing.
Parents and others authorized to consent for newborns
The bill would require their informed consent before newborn testing or screening, except in emergencies, and disclosures about confidentiality and potential legal consequences.
Hospitals and licensed health care professionals
The bill would impose consent and documentation requirements, requiring written and oral consent for tests and hospital screens but oral consent for screens outside hospitals.
Attorneys advising patients and families
Required disclosures would warn that positive results could lead to child protective services reports and advise individuals that they may want to consult legal counsel.
Headline styles
Stop Testing Pregnant People
Plain English, a few words. Used as the page title.
Sponsors
29 Co-sponsors
- Phara Souffrant Forrest
- Rebecca Seawright
- Jeffrion Aubry
- Rodneyse Bichotte Hermelyn
- Sarah Clark
- Robert C. Carroll
- Andrew Hevesi
- Jo Anne Simon
- Chantel Jackson
- Marcela Mitaynes
- Karines Reyes
- Jessica Gonzalez-Rojas
- Catalina Cruz
- Harvey Epstein
- Steven Otis
- Emily Gallagher
- Brian Cunningham
- Michaelle C. Solages
- Steven Raga
- MaryJane Shimsky
- Dana Levenberg
- Chris Burdick
- Yudelka Tapia
- Jeffrey Dinowitz
- David Weprin
- Maritza Davila
- Anna Kelles
- Sarahana Shrestha
- Zohran Mamdani
History
- Advanced to third reading cal.360
- Reported
- Referred to codes
- Print number 109b
- Amend (t) and recommit to rules
- Reported referred to rules
- Reported referred to codes
- Print number 109a
- Amend and recommit to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Ban Nonconsensual Pregnancy Drug Tests
In Senate Committee · Women's Issues · Sponsor Julia Salazar
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
109--B
2023-2024 Regular Sessions
IN ASSEMBLY (Prefiled)
January 4, 2023
Introduced by M. of A. L. ROSENTHAL, FORREST, SEAWRIGHT, AUBRY, BICHOTTE HERMELYN, CLARK, ZINERMAN, CARROLL, HEVESI, SIMON, JACKSON, MITAYNES, REYES, GONZALEZ-ROJAS, JEAN-PIERRE, BURGOS, CRUZ, EPSTEIN, OTIS, GALLAGHER, CUNNINGHAM, SOLAGES, RAGA -- read once… Show allHide
Introduced by M. of A. L. ROSENTHAL, FORREST, SEAWRIGHT, AUBRY, BICHOTTE HERMELYN, CLARK, ZINERMAN, CARROLL, HEVESI, SIMON, JACKSON, MITAYNES, REYES, GONZALEZ-ROJAS, JEAN-PIERRE, BURGOS, CRUZ, EPSTEIN, OTIS, GALLAGHER, CUNNINGHAM, SOLAGES, RAGA -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -reported and referred to the Committee on Codes -- reported and referred to the Committee on Rules -- Rules Committee discharged, bill amended, ordered reprinted as amended and recommitted to the Committee on Rules
AN ACT to amend the public health law, in relation to prohibiting drug, cannabis or alcohol testing and screening of pregnant or postpartum individuals and newborns
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2509-b to read as follows:
§ 2509-b. Drug, cannabis or alcohol testing and screening for pregnant or postpartum individuals; prohibited. 1. For purposes of this section:
(a) "drug" shall mean a controlled substance as that term is defined in section thirty-three hundred six of this chapter.
(b) "cannabis" shall mean cannabis or concentrated cannabis as those terms are defined in section 222.00 of the penal law.
(c) "drug, cannabis or alcohol test" shall mean a test using a biological sample, including, but not limited to, urine or hair, for the presence of drugs, cannabis or alcohol.
(d) "drug, cannabis or alcohol screen" shall mean the use of a validated verbal or written tool or questionnaire by a health care professional licensed, certified, or authorized under title eight of the
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00489-04-3
education law to determine use of drugs, cannabis or alcohol by a pregnant or postpartum person.
2. No health care professional licensed, certified, or authorized under title eight of the education law shall:
(a) perform a drug, cannabis or alcohol test on a person who is pregnant or up to one year postpartum unless:
(i) the pregnant or postpartum individual gives prior written and oral informed consent specific to the drug, cannabis or alcohol test; and
(ii) the performance of the drug, cannabis or alcohol test is within the scope of medical care being provided to the individual, cannabis.
(b) perform a drug, cannabis or alcohol screen in a hospital on a person who is pregnant or up to one year postpartum unless:
(i) the pregnant or postpartum individual gives prior written and oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the individual.
(c) perform a drug, cannabis or alcohol screen outside a hospital on a person who is pregnant or up to one year postpartum unless:
(i) the pregnant or postpartum individual gives prior oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the individual.
3. No health care professional licensed, certified or authorized under title eight of the education law shall:
(a) perform a drug, cannabis or alcohol test on a newborn unless:
(i) the individual authorized to consent for the newborn, as defined by subdivision two of section twenty-five hundred four of this title, gives prior written and oral informed consent specific to the drug, cannabis or alcohol test; and
(ii) the performance of the drug, cannabis or alcohol test is within the scope of medical care being provided to the newborn;
(b) perform a drug, cannabis or alcohol screen in a hospital on a newborn unless:
(i) the individual authorized to consent for the newborn, as defined by subdivision two of section twenty-five hundred four of this title, gives prior written and oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the newborn;
(c) perform a drug, cannabis or alcohol screen outside a hospital on a newborn unless:
(i) the individual authorized to consent for the newborn, as defined by subdivision two of section twenty-five hundred four of this title, gives prior oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the newborn.
4. Written and oral informed consent to a drug, cannabis or alcohol test or drug or alcohol screen shall occur at the time of testing, in language understandable to the pregnant or postpartum individual, or the individual authorized to consent for the newborn, under circumstances that provide such individual sufficient opportunity to consider whether or not to authorize the drug, cannabis or alcohol test or drug, cannabis or alcohol screen and minimize the possibility of coercion or undue influence, and shall consist of oral authorization and written authorization that is dated, signed and includes the following:
(a) a statement explaining that consenting to a drug, cannabis or alcohol test or drug, cannabis or alcohol screen is voluntary and requires written and oral informed consent, except when conditions under subdivision five of this section are met;
(b) a statement that testing or screening positive for drugs, cannabis or alcohol could have legal consequences, including, but not limited to, a report to a local child protective services agency, and that the individual may want to consult with legal counsel prior to or after consenting to a drug, cannabis or alcohol test or drug, cannabis or alcohol screen;
(c) a statement explaining the extent of confidentiality of the test or screen results;
(d) a statement of the medical purpose of the test or screen; and
(e) a general description of the test or screen.
5. Drug, cannabis or alcohol testing or drug, cannabis or alcohol screening may be performed without consent of the patient or the individual authorized to consent for a newborn when, in the health care professional's judgment, an emergency exists and the patient or newborn is in immediate need of medical attention, and an attempt to secure consent would result in delay of treatment that could increase the risk to the patient's or newborn's life or health. In the case that drug, cannabis or alcohol testing or drug or alcohol screening is performed under these circumstances, the test or screen results shall be discussed with the patient or the individual authorized to consent for the newborn, in language understandable to the patient or individuals authorized to consent for the newborn and shall consist of oral notification and written notification that is dated, signed and includes the following:
(a) a statement that testing or screening positive for drugs, cannabis or alcohol could have legal consequences, including but not limited to a potential report to a local child protective services agency, and that the patient or individual authorized to consent for the newborn may want to consult with legal counsel;
(b) a statement in the medical record with a description of the emergency that necessitated unconsented drug, cannabis or alcohol testing or drug, cannabis or alcohol screening; and
(c) a statement explaining the extent of confidentiality of the test or screen results.
6. No health care professional licensed, certified, or authorized under title eight of the education law shall refuse to treat an individual who is pregnant or up to one year postpartum or a newborn because of the patient or individuals authorized to consent for the newborn's refusal to submit to a drug, cannabis or alcohol test or drug, cannabis or alcohol screen.
7. Nothing in this section shall diminish any other requirement to obtain informed consent for a drug, cannabis or alcohol test or drug, cannabis or alcohol screen or any other procedure.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.